FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130672074> ?p ?o ?g. }

• W2130672074 endingPage "1345.e6" @default.
• W2130672074 startingPage "1337" @default.
• W2130672074 abstract "Background & AimsLiver biopsy analysis is the standard method used to diagnose nonalcoholic fatty liver disease (NAFLD). Advanced magnetic resonance imaging is a noninvasive procedure that can accurately diagnose and quantify steatosis, but is expensive. Conventional ultrasound is more accessible but identifies steatosis with low levels of sensitivity, specificity, and quantitative accuracy, and results vary among technicians. A new quantitative ultrasound (QUS) technique can identify steatosis in animal models. We assessed the accuracy of QUS in the diagnosis and quantification of hepatic steatosis, comparing findings with those from magnetic resonance imaging proton density fat fraction (MRI-PDFF) analysis as a reference.MethodsWe performed a prospective, cross-sectional analysis of a cohort of adults (N = 204) with NAFLD (MRI-PDFF, ≥5%) and without NAFLD (controls). Subjects underwent MRI-PDFF and QUS analyses of the liver on the same day at the University of California, San Diego, from February 2012 through March 2014. QUS parameters and backscatter coefficient (BSC) values were calculated. Patients were assigned randomly to training (n = 102; mean age, 51 ± 17 y; mean body mass index, 31 ± 7 kg/m2) and validation (n = 102; mean age, 49 ± 17 y; body mass index, 30 ± 6 kg/m2) groups; 69% of patients in each group had NAFLD.ResultsBSC (range, 0.00005–0.25 1/cm-sr) correlated with MRI-PDFF (Spearman ρ = 0.80; P < .0001). In the training group, the BSC analysis identified patients with NAFLD with an area under the curve value of 0.98 (95% confidence interval, 0.95–1.00; P < .0001). The optimal BSC cut-off value identified patients with NAFLD in the training and validation groups with 93% and 87% sensitivity, 97% and 91% specificity, 86% and 76% negative predictive values, and 99% and 95% positive predictive values, respectively.ConclusionsQUS measurements of BSC can accurately diagnose and quantify hepatic steatosis, based on a cross-sectional analysis that used MRI-PDFF as the reference. With further validation, QUS could be an inexpensive, widely available method to screen the general or at-risk population for NAFLD. Liver biopsy analysis is the standard method used to diagnose nonalcoholic fatty liver disease (NAFLD). Advanced magnetic resonance imaging is a noninvasive procedure that can accurately diagnose and quantify steatosis, but is expensive. Conventional ultrasound is more accessible but identifies steatosis with low levels of sensitivity, specificity, and quantitative accuracy, and results vary among technicians. A new quantitative ultrasound (QUS) technique can identify steatosis in animal models. We assessed the accuracy of QUS in the diagnosis and quantification of hepatic steatosis, comparing findings with those from magnetic resonance imaging proton density fat fraction (MRI-PDFF) analysis as a reference. We performed a prospective, cross-sectional analysis of a cohort of adults (N = 204) with NAFLD (MRI-PDFF, ≥5%) and without NAFLD (controls). Subjects underwent MRI-PDFF and QUS analyses of the liver on the same day at the University of California, San Diego, from February 2012 through March 2014. QUS parameters and backscatter coefficient (BSC) values were calculated. Patients were assigned randomly to training (n = 102; mean age, 51 ± 17 y; mean body mass index, 31 ± 7 kg/m2) and validation (n = 102; mean age, 49 ± 17 y; body mass index, 30 ± 6 kg/m2) groups; 69% of patients in each group had NAFLD. BSC (range, 0.00005–0.25 1/cm-sr) correlated with MRI-PDFF (Spearman ρ = 0.80; P < .0001). In the training group, the BSC analysis identified patients with NAFLD with an area under the curve value of 0.98 (95% confidence interval, 0.95–1.00; P < .0001). The optimal BSC cut-off value identified patients with NAFLD in the training and validation groups with 93% and 87% sensitivity, 97% and 91% specificity, 86% and 76% negative predictive values, and 99% and 95% positive predictive values, respectively. QUS measurements of BSC can accurately diagnose and quantify hepatic steatosis, based on a cross-sectional analysis that used MRI-PDFF as the reference. With further validation, QUS could be an inexpensive, widely available method to screen the general or at-risk population for NAFLD." @default.
• W2130672074 created "2016-06-24" @default.
• W2130672074 creator A5018653540 @default.
• W2130672074 creator A5025819859 @default.
• W2130672074 creator A5033908566 @default.
• W2130672074 creator A5039676124 @default.
• W2130672074 creator A5051920085 @default.
• W2130672074 creator A5053930455 @default.
• W2130672074 creator A5070587838 @default.
• W2130672074 creator A5076701556 @default.
• W2130672074 creator A5085487679 @default.
• W2130672074 creator A5086583445 @default.
• W2130672074 creator A5088370371 @default.
• W2130672074 date "2015-07-01" @default.
• W2130672074 modified "2023-10-18" @default.
• W2130672074 title "Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique" @default.
• W2130672074 cites W1571767699 @default.
• W2130672074 cites W1574141134 @default.
• W2130672074 cites W1622799587 @default.
• W2130672074 cites W1963682935 @default.
• W2130672074 cites W1963683487 @default.
• W2130672074 cites W1965085728 @default.
• W2130672074 cites W1967244395 @default.
• W2130672074 cites W1972893099 @default.
• W2130672074 cites W1977954856 @default.
• W2130672074 cites W1980932730 @default.
• W2130672074 cites W1983496515 @default.
• W2130672074 cites W1999426013 @default.
• W2130672074 cites W1999517566 @default.
• W2130672074 cites W2001837599 @default.
• W2130672074 cites W2003971999 @default.
• W2130672074 cites W2004177180 @default.
• W2130672074 cites W2010450923 @default.
• W2130672074 cites W2012126091 @default.
• W2130672074 cites W2017741306 @default.
• W2130672074 cites W2020969286 @default.
• W2130672074 cites W2022296797 @default.
• W2130672074 cites W2025106732 @default.
• W2130672074 cites W2030895895 @default.
• W2130672074 cites W2034087479 @default.
• W2130672074 cites W2059613020 @default.
• W2130672074 cites W2064403130 @default.
• W2130672074 cites W2066473433 @default.
• W2130672074 cites W2069053014 @default.
• W2130672074 cites W2069846825 @default.
• W2130672074 cites W2070200234 @default.
• W2130672074 cites W2084461928 @default.
• W2130672074 cites W2092091717 @default.
• W2130672074 cites W2094944089 @default.
• W2130672074 cites W2095755100 @default.
• W2130672074 cites W2098555833 @default.
• W2130672074 cites W2098988372 @default.
• W2130672074 cites W2099339773 @default.
• W2130672074 cites W2106937897 @default.
• W2130672074 cites W2110608362 @default.
• W2130672074 cites W2126025827 @default.
• W2130672074 cites W2136909828 @default.
• W2130672074 cites W2151165168 @default.
• W2130672074 cites W2159741243 @default.
• W2130672074 cites W2161971256 @default.
• W2130672074 cites W2166321004 @default.
• W2130672074 cites W2169241961 @default.
• W2130672074 cites W2419420142 @default.
• W2130672074 cites W4211191129 @default.
• W2130672074 cites W4246242867 @default.
• W2130672074 cites W93558354 @default.
• W2130672074 doi "https://doi.org/10.1016/j.cgh.2014.11.027" @default.
• W2130672074 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4454635" @default.
• W2130672074 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25478922" @default.
• W2130672074 hasPublicationYear "2015" @default.
• W2130672074 type Work @default.
• W2130672074 sameAs 2130672074 @default.
• W2130672074 citedByCount "188" @default.
• W2130672074 countsByYear W21306720742015 @default.
• W2130672074 countsByYear W21306720742016 @default.
• W2130672074 countsByYear W21306720742017 @default.
• W2130672074 countsByYear W21306720742018 @default.
• W2130672074 countsByYear W21306720742019 @default.
• W2130672074 countsByYear W21306720742020 @default.
• W2130672074 countsByYear W21306720742021 @default.
• W2130672074 countsByYear W21306720742022 @default.
• W2130672074 countsByYear W21306720742023 @default.
• W2130672074 crossrefType "journal-article" @default.
• W2130672074 hasAuthorship W2130672074A5018653540 @default.
• W2130672074 hasAuthorship W2130672074A5025819859 @default.
• W2130672074 hasAuthorship W2130672074A5033908566 @default.
• W2130672074 hasAuthorship W2130672074A5039676124 @default.
• W2130672074 hasAuthorship W2130672074A5051920085 @default.
• W2130672074 hasAuthorship W2130672074A5053930455 @default.
• W2130672074 hasAuthorship W2130672074A5070587838 @default.
• W2130672074 hasAuthorship W2130672074A5076701556 @default.
• W2130672074 hasAuthorship W2130672074A5085487679 @default.
• W2130672074 hasAuthorship W2130672074A5086583445 @default.
• W2130672074 hasAuthorship W2130672074A5088370371 @default.
• W2130672074 hasBestOaLocation W21306720741 @default.
• W2130672074 hasConcept C126322002 @default.
• W2130672074 hasConcept C126838900 @default.
• W2130672074 hasConcept C143409427 @default.

• next